MedPath

Functional Renal Hemodynamics in Patients with Renal Artery Stenosis 3

Recruiting
Conditions
Renal artery stenosis
Registration Number
NL-OMON27493
Lead Sponsor
Dutch Kidney Foundation, Philips N.V.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Age > 18
-Written informed consent
-Clinical indication for percutaneous transluminal renal angioplasty
-Clinically and hemodynamically stable
-CT-angiogram or MR-angiogram of the renal arteries
-Available or scheduled renography

Exclusion Criteria

-Known atrial fibrillation with irregular ventricular response rate
-Increased risk for contrast nephropathy defined as presence of renal impairment (eGFR <30ml/min) according to the Guideline Safe Use of Contrast Media of the Radiology Society of the Netherlands (November 2017)
-Women of child bearing age not on active birth control
-Inability to sign an informed consent, due to any mental condition that renders the subject unable to understand the nature, scope, and possible consequences of the trial or due to mental retardation or language barrier

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Receiver operating characteristics for predicting ambulatory blood pressure response after renal angioplasty by (1) the hyperemic pressure gradient and (2) the hyperemic pressure gradient and the renal flow reserve.
Secondary Outcome Measures
NameTimeMethod
Intra-class correlation and level and limits of agreement (Bland-Altman plot) between the CFD-predicted and the invasively measured mean translesional hyperemic pressure gradient (MHG) of a renal artery stenosis. <br>Renal function response after renal angioplasty and an exploratory analysis of the predictive power for renal function improvement and blood pressure response by the hyperemic pressure gradient, the renal flow reserve and related hemodynamic parameters.
© Copyright 2025. All Rights Reserved by MedPath